4-Nitropicolinaldehyde

Catalog No.: 
ACMQUF547
CAS No.: 
108338-19-8
Molecular Formula: 
C6H4N2O3
Molecular Weight: 
152.11
4-Nitropicolinaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$392.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Nitropicolinaldehyde
IUPAC Name4-nitropicolinaldehyde
MDL No.MFCD07374896
Molecular FormulaC6H4N2O3
Molecular Weight152.11
SMILES[O-][N+](=O)C1=CC(C=O)=NC=C1
InChI KeyXWFNGAKFHUOJCQ-UHFFFAOYSA-N
Synonym4-Nitropicolinaldehyde | 108338-19-8 | 4-Nitropyridine-2-carbaldehyde | 2-Pyridinecarboxaldehyde, 4-nitro- | SCHEMBL2085482 | DTXSID50561878 | XWFNGAKFHUOJCQ-UHFFFAOYSA-N | MFCD07374896 | ZB0355 | AKOS006285848 | AB40661 | 4-NITRO-PYRIDINE-2-CARBALDEHYDE | AS-50516 | FT-0757102 | P1
CAS No.108338-19-8
PubChem CID14578929

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMQUF547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKJZG345 route compound structure diagram
    ACKJZG34598197-88-7In Stock
  2. Then
  3. ACMQUF547 route product structure diagram
    ACMQUF547108338-19-8
Inquiry

2. ACMQUF547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKMBA197 route compound structure diagram
    ACKMBA1976945-67-1In Stock
  4. Then
  5. ACMQUF547 route product structure diagram
    ACMQUF547108338-19-8
Inquiry

3. ACMQUF547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQGV873 route compound structure diagram
    ACAQGV8731122-61-8In Stock
  4. Then
  5. ACMQUF547 route product structure diagram
    ACMQUF547108338-19-8
Inquiry

Comments (0)